Phenolic Constituents of Eucalyptus camaldulensis Dehnh , with Potential Antioxidant and Cytotoxic Activities by Abdel-Nasser Singab et al.
ORIGINAL ARTICLE      
 
The article was published by Academy of Chemistry of Globe Publications 
www.acgpubs.org/RNP © Published 03 /15/2011 EISN:1307-6167 
 
 
 
 
Rec. Nat. Prod. 5:4 (2011) 271-280 
 
Phenolic Constituents of Eucalyptus camaldulensis Dehnh, with 
Potential Antioxidant and Cytotoxic Activities 
 
Abdel-Nasser Singab
1
,
 Nahla Ayoub
1, Eman Al-Sayed
1,2*,  
Olli Martiskainen
2, Jari Sinkkonen
2 and Kalevi Pihlaja
2 
 
    1 Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, 11566 Cairo, Egypt.   
     
2 Laboratory of Organic Chemistry and Chemical Biology,Department of Chemistry, University of 
Turku, FI-20014 Turku, Finland.  
  
(Received September 28, 2010; Revised February 5, 2011, Accepted February 15, 2011) 
 
Abstract:  A liquid chromatography-diode array detection-electrospray ionization mass spectrometric (HPLC–
PDA–ESI/MS/MS) method was used for separation and characterization of the phytoconstituents of the aqueous 
acetone leaf extract of Eucalyptus camaldulensis Dehnh (Myrtaceae). The employed method was optimized for 
separation,  identification  and  quantification  of  fifty  six  compounds  including  ellagitannins,  flavonoids, 
phloroglucinol derivatives and galloyl esters.  The antioxidant effect was determined in vitro using 1,1-diphenyl-
2-picrylhydrazyl (DPPH
·), hydroxyl radical and super oxide anion radical scavenging assays. The cytotoxicity of 
the aqueous acetone extract was evaluated on MCF-7, Hep-2, HepG-2, HeLa, HCT-116 and Caco-2 cell lines. 
The results indicated that most of the fractions exhibited strong antioxidant activity. The aqueous acetone extract 
reduced the viability of all cell lines in a dose-dependent manner, and was more active on MCF-7 and HCT-116 
cell lines.   
 
Keywords:  Myrtaceae; Eucalyptus camaldulensis; DPPH; 2-deoxy-2-ribose; HPLC–PDA–ESI/MS/MS; 
cytotoxicity. 
 
1. Introduction 
 
Eucalyptus camaldulensis Dehnh, also known as river red gum or Murray red gum, is a tree of 
the genus Eucalyptus and is native to Australia [1]. E. camaldulensis is probably the most widespread 
Eucalyptus species in Australia [2]. Several species of Eucalyptus are used in traditional medicine as 
antiseptics, and against upper respiratory tract infections, such as common cold, influenza and sinus 
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congestion [3,4]. The essential oil obtained from these plants has a therapeutic application in treatment 
of pulmonary infections by inhalation [5,6]. Previous studies on the essential oil of the flowers of E. 
camaldulensis revealed the presence of 1,8-cineole, β-pinene and spathulenol as the most abundant 
constituents [7]. The essential oil of the leaves was found to contain p-cymene, γ-terpinene, α-pinene, 
1,8-cineole, terpinen-4-ol, α-terpineol,  carvacrol and thymol as the major components [8]. The major 
components of the essential oil of the fruits were aromadendrene, α-pinene, drimenol, and cubenol [9]. 
A pentacyclic triterpenoid, named camaldulin along with ursolic acid lactone acetate and ursolic acid 
lactone were isolated from E. camaldulensis, all exhibited spasmolytic action [10]. Later the same 
authors  isolated  another  triterpenoid  acid  named  eucalyptanoic  acid  which  also  exhibited  a 
spasmolytic action [11]. Some flavonoid glycosides were isolated from the leaves of E. camaldulensis 
[12]. 
Numerous physiological processes in the body produce reactive oxygen species as byproducts. 
Overproduction of such free radicals can cause oxidative damage to biomolecules (e.g. lipids, proteins, 
DNA),  eventually  leading  to  many  chronic  diseases,  such  as  atherosclerosis,  cancer  and  other 
degenerative  diseases  [13].  Reactive  oxygen  species  (ROS)  such  as  superoxide  anion  (O2
-.)  and 
hydroxyl radicals (OH
.) are known to act in all phases of the carcinogenesis process, namely initiation, 
promotion and progression. ROS exert a mutagenic effect by oxidizing DNA bases, and also cause 
DNA strand breaks, eventually increasing the risk of cancer development [14]. Dietary polyphenols 
act as  antioxidants  and preventing injury  caused by free  radicals [14].  Polyphenols exhibit  strong 
antioxidant properties and scavenge free radicals [14]. Moreover, polyphenolic compounds have been 
shown  to  inhibit  the  carcinogenic  process  through  cell  cycle  arrest,  regulation  of  cell  death 
machineries, and arresting proliferation of cancer cells [14]. 
 
Chemoprevention is a rapidly growing practical approach that focuses on cancer prevention by 
the administration of one or more synthetic or naturally occurring agents to suppress or reverse the 
process of carcinogenesis. It is becoming increasingly clear that chemopreventive compounds present 
in diet offer great potential in the fight against cancer by inhibiting the process of carcinogenesis 
through  regulation  of  cell-defensive  and  cell  death  machineries  [15].  Dietary  chemopreventive 
substances are regarded as being generally safe, inexpensive and they have been found to contain 
various phytochemicals which are antioxidant in nature [15]. In Japan, leaf extracts of E. globulus are 
used as food additive for the prevention of many chronic diseases [16]. The goal of the work described 
herein was  to  develop  a  simple  and rapid  method  for the  identification  and  quantification  of  the 
phenolic compounds of E. camaldulensis Dehnh using HPLC–PDA–ESI/MS/MS and to evaluate the 
use of its extract as an antioxidant and natural chemopreventive agent. This work represents the first 
study  that  utilizes  the  HPLC–PDA–ESI/MS/MS  technique  for  in-depth  identification  and 
quantification of the phenolic composition of E. camaldulensis Dehnh. The employed method can be 
used to qualitatively describe the phytochemical composition of different plant extracts and /or herbal 
preparations. 
 
2. Materials and Methods 
 
2.1. Plant Material  
 
The leaves of E. camaldulensis Dehnh were collected in July 2007 from the zoo botanical 
garden, Giza, Egypt. The plant was botanically identified by the staff at the herbarium of the botanical 
garden of the zoo, Giza, Egypt. Voucher specimen was deposited at the herbarium of the faculty of 
pharmacy, Ain shams university, Cairo, Egypt (ASU-ECM2007). 
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2.2  Extraction and Isolation 
 
Air-dried powdered leaves of E. camaldulensis (50 g) were extracted three times with 70% 
aqueous acetone (each 0.5 L). The total extract was evaporated under vacuum to remove the organic 
solvent, the remaining aqueous solution was freeze-dried to obtain a dry powder (5 g) representing the 
total aqueous acetone extract. Fractionation of 3 g of this extract on a column packed with Sephadex 
LH-20 (3×30 cm), eluted with H2O followed by H2O-MeOH mixtures of decreasing polarities (2 L 
each), yielded 4 major fractions (I-IV). Fraction I was eluted with water, fraction II was eluted with 
30% MeOH, 60%MeOH was used for elution of fraction III. The last fraction was eluted with MeOH.  
 
2.3  Chemicals 
 
2,2-diphenyl-1-picrylhydrazyl  (DPPH),  L-ascorbic  acid,  quercetin,  gallic  acid  and  phenazine 
methosulfate  (PMS)  were  obtained  from  Sigma-Aldrich  GmbH,  Germany;  nitroblue  tetrazolium 
(NBT) was obtained from BioChemika, Germany, nicotinamide adenine dinucleotide (NADH) was 
obtained  from  Merck,  Sweden.  RPMI-1640,  penicillin,  streptomycin,  Sulphorhodamine-B,  trypan 
blue, trypsin, acetic acid and trichloroacetic acid were obtained from Sigma Chemical Co., St. Louis, 
U.S.A. Fetal bovine serum (FBS) and doxorubicin were obtained from Sigma Chemical Co., St. Louis, 
U.S.A. Folin-Ciocalteu reagent was obtained from Sigma-Aldrich GmbH, Germany.                                                      
 
2.4  Sample Preparation for LC/PDA-ESI/MS/MS 
 
Part of each fraction was dissolved in 20%MeOH (20 mg/mL) and the solution was filtered 
through 0.45 µm membranes. 
 
2.5  Analysis of the Phenolic Composition by LC/PDA-ESI/MS/MS 
 
LC-HRESIMS was performed on a Bruker Daltonics micrOTOF-Q (API) Time-of-Flight mass 
spectrometer  (Bremen,  Germany),  coupled  to  1200  series  HPLC  system  (Agilent  Technologies, 
Waldbronn,  Germany),  equipped  with  a  high  performance  autosampler,  binary  pump,  and  variable 
wavelength  detector  G  1314B,  G  1314  C(SL).  Chromatographic  separation  was  performed  on  a 
Superspher 100 RP-18 (75 × 4 mm i.d.; 4 µm) column (Merck, Darmstadt, Germany). The mobile 
phase consisted of acetonitrile (A) and 0.4 % formic acid (B). The elution profile was 0–3 min, 100% B 
(isocratic); 3–30 min, 0–30% A in B; 30–35 min, 30–70% A; 35–45, 70% A (isocratic) with constant 
flow rate 0.5 mL/min. The ionization technique was ion spray (pneumatically assisted electrospray). 
The mass spectrometer was operated in negative mode. Mass detection was performed in full scan 
mode  in  the  range  50–2000  m/z.  The  following  settings  were  applied  to  the  instrument:  capillary 
voltage, 4000 V; end plate offset, -500 V. Heated dry gas (N2) flow rate was 10 L/min; the dry gas 
temperature was 200
oC. The gas flow to the nebulizer was set at a pressure of 1.6 bar. For collision-
induced dissociation (CID) MS/MS measurements, the voltage over the collision cell varied from 20 to 
70 eV. Argon was used as collision gas. The mass spectrometer was operated in data-dependent mode 
to automatically select the 3 most abundant precursor ions. Data analysis software was used for data 
interpretation. Sodium formate was used for calibration at the end of the LC/MS run.  
 
2.6  Hydroxyl Radical Scavenging Activity (Deoxyribose Assay)  
 
The assay was carried out as reported before [17]. The reaction mixture contained 2.8 mM 2-
deoxy-2-ribose  (dissolved  in  KH2PO4–K2HPO4  buffer,  pH  7.4,  20  mM),  100  µM  FeCl3,  104  µM 
EDTA, 1.0 mM H2O2 and 100 µM ascorbic acid. Different concentrations of the tested samples were 
added.  After  an  incubation  period  of  1  h.  at  37  °C,  the  extent  of  deoxyribose  degradation  was 
measured by the reaction of formed malonaldehyde with thiobarbituric acid (TBA). Equal volumes of 
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cooling the reaction mixture the absorbance was measured at 532 nm against a blank. The inhibition 
percentage of the radical scavenging activity was calculated using the equation:  Inhibition (%) = 100 
– 100 (AS/ A0) where A0 is the absorbance of the blank and AS is absorbance of the sample. All assays 
were  conducted  in  triplicates.  Quercetin  was  used  as  a  positive  control.  The  IC50  values  were 
calculated using four parameter logistic curve (Hill equation) (GraphPad Prism 5.00) and data were 
statistically evaluated using Student’s t-test (SigmaPlot 11.0). 
 
2.7  DPPH
· Radical Scavenging Assay 
 
The assay was done as reported before [18,19] with some modifications to be carried out in 
microtiter plate. Twenty µL of samples at different concentrations, standards (quercetin, and gallic 
acid) or solvent in case of blank was pipetted into each well of a 96-well plate, followed by 280 µL of 
0.25 mM methanolic solution of DPPH. The mixture was incubated at room temperature in dark for 30 
min, and the absorbance at 520 nm was measured with a Multiskan Ascent V1.24 microplate reader. 
All  assays  were  conducted  in  triplicates.  The  inhibition  percentage  was  calculated  as  in  the 
deoxyribose assay. IC50 values were calculated from three independent experiments. Quercetin and 
gallic acid were used as positive controls. 
 
2.8. Superoxide Anion Radical Scavenging Activity 
 
Superoxide  anion  scavenging  activity  of  all  the  tested  samples  was  determined  using  the 
previous  method  [13]  with  some  modifications.  Superoxide  radicals  were  generated  in  the  PMS-
NADH system and assayed by the reduction of NBT. Test solution (60 µL), 60 µL of 677 µM NADH 
solution, 60 µL of 144 µM NBT solution and 60 µL of 60 µM PMS solution in 0.1M phosphate buffer 
pH 7.4, were added to a microwell plate and incubated at room temperature for 5 min. The absorbance 
was read at 550 nm. IC50 values were calculated as before. L-ascorbic acid was used as a positive 
control. The assay was conducted in triplicates and repeated at least three times. 
 
2.9. Determination of Total Phenols 
 
Total  phenolics  were  determined  according  to  the  previous  method  [20]  with  some 
modifications. Fifty µL of the methanolic solution of each sample was added to 100 µL of methanol and 
mixed with 100 µL of Folin-Ciocalteu reagent. The mixture was shaken and allowed to stand at room 
temperature  for  3  min  before  the  addition  of  500  µL  of  20%  Na2CO3.  The  solution  was  mixed 
thoroughly and the absorbance was measured at 730 nm after 2 h. Results were expressed as gallic acid 
equivalents per gram dry weight of each sample from a calibration curve of gallic acid (0-500 µg/mL).  
 
2.10. Determination of Total Favonoid Content 
 
Flavonoid content was determined according to a reported method [21]. Quercetin was used as 
a standard. An aliquot of either the methanolic solution of the samples or standard solution was mixed 
with  an  equal  volume  of  AlCl3.6H2O  (0.2%).  Absorbance  was  measured  at  367  nm.  Results  were 
expressed as mg of quercetin equivalents per gram dry weight of each sample from a calibration curve 
of the standard (0-500 µg/mL). 
 
2.11. Cell culture 
 
Different  tumor  cell  lines,  including  MCF-7  (breast  adenocarcinoma),  Hep-2  (human 
epithelial  laryngeal  carcinoma),  HepG-2  (hepatocellular  carcinoma),  HeLa  (human  cervix 
adenocarcinoma), HCT-116 (colorectal adenocarcinoma) and Caco-2 (colon adenocarcinoma) were 
purchased from American Type Cell Culture (ATCC). All cell lines were maintained in RPMI-1640 
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mg/L streptomycin, and 100 IU/mL penicillin at 37 °C in a humidified atmosphere of 5% CO2. Cell 
viability was estimated by trypan blue exclusion test. 
2.12. Cytotoxicity assay 
 
Cytotoxicity was tested against cancer cell lines according to the procedure adopted by the 
National Cancer Institute (NCI, USA), that uses the protein-binding dye Sulphorhodamine-B (SRB) to 
assess  cell  growth  [22].  The  cell  viability  was  compared  to  that  of  untreated  controls.  Briefly,  a 
monolayer cell culture was trypsinized (0.025 % trypsin and 0.02% EDTA).  Cells were harvested in 
96-well microtiter plates (5000 cells/well). After a 24 h incubation to allow the cell to attach, different 
concentrations of the samples or the reference drug doxorubicin were added. The plates were then 
incubated at 37 °C for 2 days in a 5% CO2 atmosphere. This was followed by treatment with 50 µL 
cold 50 % trichloroacetic acid (TCA) at 4°C for 1 hr. After washing with distilled water, the plates 
were stained for 30 min at room temperature with 50 µL 0.4 % SRB dissolved in 1 % acetic acid, and 
subsequently washed with 1% acetic acid to remove unbound stain, 10 mM tris base (pH: 10.5) was 
used to solubilize the dye. The plates were shaken vigorously, and the absorbance was measured using 
a Victor microplate reader (PerkinElmer Life Science) at 564 nm. The percentage of cell survival was 
calculated  from  the  following  formula:  Surviving  fraction  (%)  =  (Absorbance  of  treated  cells)/ 
(Absorbance of control cells) × 100 (%). The assay was conducted in 6 replicates for each cell line. 
The IC50 values were calculated from the dose-response curve (GraphPad Prism 5.00). Doxorubicin 
was used as a positive control.  
 
3.  Results and Discussion   
In  this study,  HPLC–PDA–ESI/MS/MS was utilized  to  separate and  identify the  different 
phenolic compounds of E. camaldulensis extract. The subsequent fragmentation of the predominant 
negative ions in the MS/MS mode was used to obtain more information about the molecular masses of 
the  different  compounds.  Using  this  method,  fifty  six  compounds  were  tentatively  identified  and 
quantified. The fractionation process was conducted by fractionating 3 g. of the 70% aqueous acetone 
extract over a column packed with Sephadex LH-20. The elution started with water, followed by H2O-
MeOH mixtures of decreasing polarities to obtain 4 major fractions (I-IV). Part of each fraction was 
subjected to high performance liquid chromatography, coupled to photodiode-array and electrospray 
ionization  mass  spectrometric  analysis  (HPLC–PDA–ESI/MS/MS)  in  order  to  obtain  a  tentative 
identification of its components. The results are listed in Tables 1-4.   
The major components of the first fraction (eluted with water) were identified as HHDP-
glucopyranose,  chlorogenic  acid  and  phloroglucinol  derivatives.  The  second  fraction,  which  was 
eluted  with  30%  MeOH  was  found  to  contain  different  galloyl-HHDP-glucopyranose  positional 
isomers  and  pedunculagin  as  major  components.  The  fraction  eluted  with  60%  MeOH  was 
predominantly composed of digalloyl-HHDP-glucopyranose (tellimagrandin I) α and β anomers. The 
last fraction, eluted with MeOH, was composed of a mixture of ellagitannin dimers. The HPLC–PDA–
ESI/MS/MS profiling of the obtained fractions indicated that ellagitannins were the most predominant 
components of fractions II, III and IV. 
Most of the obtained fractions exhibited considerable inhibitory activity in 1,1-diphenyl-2-
picrylhydrazyl (DPPH
·), hydroxyl radical and super oxide anion radical scavenging assays (Table 5). 
The most active fractions in the DPPH
· assay were found to be fraction III (60% MeOH) and fraction 
IV (MeOH fraction), with IC50 values of 13.4 µg/mL, which indicated that these fractions produced 
higher DPPH
· scavenging activity when compared with standard antioxidant compounds (quercetin 
and gallic acid). While in the deoxyribose assay, the 30% MeOH, MeOH fractions produced more 
hydroxyl radical scavenging (IC50: 22.0 and 19.2 µg/mL respectively.  The 30% MeOH and 60% 
MeOH fractions exhibited the highest superoxide anion radical scavenging activity, with IC50 values 
of 43.9 and 50.9 µg/mL respectively.  The water fraction exhibited the least antioxidant activity in the 
three assays. These results were consistent with those obtained from the determination of the total 
phenol content and flavonoid content assays. The cytotoxicity of the total extract was evaluated on 
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acetone extract reduced viability of all cell lines in a dose-dependent manner. The cytotoxic effect of 
the total extract was greater on MCF-7 and HCT-116 cell lines, with IC50 values of 36.5, and 33.3 
µg/mL respectively (Table 6).  
Phytochemicals have been shown to be effective in preventing malignant transformation of 
cells in culture and experimentally induced tumorigenesis in various animal models. Mechanistically, 
chemoprevention  with  dietary  phytochemicals  could  be  achieved  by  stimulating  inactivation  of 
potential carcinogens, inhibition of abnormal cell proliferation, induction of apoptosis and delaying 
angiogenesis  [23].  The  present  study  was  undertaken  to  investigate  the  potential  of  Eucalyptus 
camaldulensis Dehnh. extract as a chemopreventive agent by evaluating its effect on oxidation, viable 
cell number and by evaluating the sensitivity of different cancer cell lines to the extract. The results of 
the present study demonstrated that the aqueous acetone extract exhibited a dose-dependent growth 
inhibitory effect after a continuous exposure during a 48 h period. The cytotoxic effect was greater on 
MCF-7 and HCT-116 cell lines.  
In conclusion, we have developed a method to separate, identify and estimate for the first time 
the amounts of different  phenolic compounds  of the aqueous acetone  extract  of E. camaldulensis 
Dehnh. Also we have shown that this extract and its associated antioxidants possess a strong potential 
to develop a chemopreventive agent against various human cancers, especially for breast and colon 
cancers which are considered to be among the most common cancers in the world. This finding is 
important from a nutritional point of view, because the extract may induce beneficial health effects 
due to its high antioxidant properties, and thus may be used as a dietary supplement for the prevention 
of cancer and other chronic diseases. Future studies to determine the mechanistic basis of the cytotoxic 
effects  of  E.  camaldulensis  extract,  together  with  other  studies  on  the  bioavilability,  toxicity  and 
antitumor effects using animal models are now under investigation. 
 
 
   Table 1.  LC-PDA-ESI/MS/MS Identification of the major constituents of E. camaledulensis fraction I 
(water fraction) 
 
 
 
 
 
 
 
N  tR   DAD  (M-H)
-  Fragments  Tentative structural 
assignment 
% 
Area 
1  2.8  196.4, 213.0, 256.7 (sh)  481.06  300.99, 275.01, 257.01, 245.01  HHDP-glucopyranose  8.07 
2  3.4  196.4, 213.0, 256.7 (sh)  481.06  301.00, 275.02  HHDP-glucopyranose  6.28 
3  4.6  213.0, 271.0   331.06  169.01 , 125.02  galloylglucopyranose   4.11 
4  6.2  213.8, 271.0  331.06  169.01 , 125.02  galloylglucopyranose   2.10 
5  9.3  211.3, 268.9  343.06  191.05, 169.01, 125.02  galloyl quinic acid  2.83 
6  10.4  211.0, 271.0  343.06  191.05, 169.01, 125.02  galloyl quinic acid  3.59 
7  11.0  214.8, 273.0  325.05  169.01 , 125.02  galloyl shikimic acid  2.44 
8  14.5  202.2, 254.9 sh, 273.3  539.09  237.83, 205.05  phloroglucinol derivative  3.41 
9  13.6  208.9, 295.5  389.11  305.07  unidentified  3.18 
10  15.4  211.3, 273.3, 302.0  495.08  191.05, 169.01, 125.02  phloroglucinol derivative  12.15 
11  15.5  214.8, 250.0sh, 292.5sh, 
322.6 
353.08  191.03  chlorogenic acid  14.20 
12  16.3  214.8, 271.0  483.08  169.01 , 125.02  digalloylglucopyranose  4.25 
13  17.0  200.2, 275.7, 303.7 (sh)  389.11  209.80  unidentified  2.28 
14  19.1  200.2, 275.7, 302.0 (sh)  523.11  371.10, 337.09  unidentified  3.24 
15  21.3  202.2, 218.0, 25.41, 
291.0 sd, 324.7 
537.14  387.13, 375.09   cypellocarpin B   8.08 
16  21.9  222.6, 273.3  421.11  313.05, 169.01 , 125.02  benzyl-galloylglucose  8.16 
17  23.4  253.1, 351.8  477.55  301.03, 271.02, 255.03, 151.00  quercetin glucuronide  5.15 
18  25.0  262.5, 338.6  461.34  285.08, 257.14, 229.05  kaempferol glucuronide  3.36 
19  26.9  264.5, 333.8  497.17  169.01, 125.02  unidentified  2.86 277                                Phenolic from Eucalyptus camaldulensis 
 
 
Table 2. LC-PDA-ESI/MS/MS Identification of the major constituents of E. camaledulensis fraction 
II (30%MeOH)  
 
Table 3. LC-PDA-ESI/MS/MS Identification of the major constituents of E. camaledulensis fraction III 
(60%MeOH)  
 
 
% 
Area 
Tentative structural assignment  Fragments  (M-H)
-  DAD  tR  N 
3.33  galloyl-HHDP-glucopyranose  301.00, 275.01, 249.03, 
169.01 
633.07  220.5, 262.5  4.3  1 
13.38  galloyl-HHDP-glucopyranose  301.00, 275.01, 249.04, 
169.01 
633.07  218.6, 262.5  4.8  2 
9.88  galloyl-HHDP-glucopyranose  301.00, 275.01, 249.04, 
169.01 
633.07  218.6, 262.5  5.5  3 
6.10  vescalagin  631.05, 301.00  933.56  214.8, 273.0 (sh)  8.3  4 
15.09  galloyl-HHDP-glucopyranose  301.00, 275.01, 249.03, 
169.01 
633.07  218.6, 262.5  8.7  5 
9.40  pedunculagin isomer  481.06, 301.0, 275.02  783.06  220.5, 273.0 (sh)  9.6  6 
1.10  castalagin  631.05, 301.00  933.06  214.8, 273.0 (sh)  9.9  7 
1.76  digalloylglucopyranose  313.06, 169.01  483.08  214.8, 271.0  11.1  8 
6.58  galloyl-HHDP-glucopyranose  301.00, 275.01, 249.03, 
169.01 
633.07  205.6, 264.5  11.7  9 
8.63   pedunculagin isomer  481.06, 301.0, 275.02  783.06  220.5, 273 (sh)  12.2  10 
1.40  valoneoyl-HHDP-glucopyranose  907.08, 301.00, 169.01  951.07  211.3 , 263.0  13.4  11 
2.28  digalloylglucopyranose  313.06, 169.01  483.08  214.8, 271.0  13.9  12 
0.56  pterocarinin A   935.05, 633.08, 301.00, 
169.01, 125.02 
1067.63  205.8, 264.8 (sh)  14.8  13 
2.06  galloyl-HHDP-glucopyranose  301.00, 275.01, 249.03, 
169.01 
633.07  214.8, 264.5  15.5  14 
1.70  galloyl-HHDP-glucopyranose  301.00, 275.01, 249.03, 
169.01 
633.07  205.6, 264.5  16.4  15 
4.17  valoneoyl-HHDP-glucopyranose  907.08, 301.00, 169.01  951.07  214.8 ,263.0  17.0  16 
1.65  valoneic acid dilactone  425.01, 301.00, 169.01  469.00  211.3, 251.4, 363.7  18.3  17 
1.14  unidentified  527.13, 473.83, 375.09  679.14  213.0, 271.0  18.6  18 
2.59  galloyl  Cypellocarpin B  
  537.19  689.21  210.0, 255.0, 273.3  21.7  19 
2.64  quercetin pentoside  301.01, 271.02,  255.03  433.04  200.2, 256.7, 346.3  22.7  20 
2.08  ellagic acid derivative  447.10, 300.99, 315.01  635.20  200.2, 253.1, 357.5  24.1  21 
% 
Area 
Tentative structural assignment  Fragments  (M-2H)
2-  (M-H)
-  DAD  tR  N 
6.18  pedunculagin isomer  481.06, 301.00, 275.02    783.06  218.6, 273 (sh)  9.5  1 
6.75  ellagitannin dimer   785.08, 765.05, 633.07,  
301.00, 169.02 
708.08  1417.16  214.8, 262.5  10.2  2 
1.62  ellagitannin dimer   785.08, 765.05, 633.07,  
301.00, 169.02 
708.08  1417.16  214.6, 262.5  12.2  3 
5.25  pedunculagin isomer  481.06, 301.00, 275.03    783.07  218.6, 273 (sh)  12.7  4 
9.79  sanguiin H10-like ellagitannin dimer  935.07, 785.08, 765.05, 
633.07,  301.00, 169.02 
784.08  1569.17  214.8, 262.4  13.6  5 
27.94  digalloyl-HHDP- glucopyranose  
(tellimagrandin I) 
301.00, 275.02, 169.01    785.08  217.0, 268.8  14.9  6 
1.02  galloyl-bis-HHDP-glucopyranose isomer  633.07,  301.00, 169.02    935.07  214.8, 264.4  15.6  7 
31.97  digalloyl-HHDP- glucopyranose  
(tellimagrandin I) 
 301.00, 275.02, 169.01    785.08  216.6, 268.8  16.4  8 
1.45  valoneoyl-digalloyl-glucopyranose  635.09,  301.00, 169.01    953.08  214.8, 260.5  16.8  9 
1.59  ellagitannin dimer   935.06, 633.07,  301.00, 
169.02 
859.08  1720.16  214.8, 266.6  17.0  10 
2.70  valoneic acid dilactone  425.01, 301.00, 169.01    469.00  213.0, 254.9, 
360.6 
18.2  11 
0.24  valoneoyl-digalloyl-glucopyranose  301.00, 169.01    953.09  211.3, 268.8  19.4  12 
1.79  tetragalloylglucopyranose  465.07, 313.05, 169.01    787.09  213.0 , 273.3  21.1  13                                  Singab et al. Rec. Nat. Prod. (2011) 5:4 271-280                                        278 
 
 
Table 4. LC-PDA-ESI/MS/MS Identification of the major constituents of E. camaledulensis fraction IV 
(MeOH) 
 
  
 
Table  5.  Antioxidant  activity  of E.  camaledulensis  fractions  using DPPH,  deoxyribose  and  super 
oxide anion radical scavenging assays. 
Means of three IC 50  replicates ± S.E (µg/mL); mg GAE g−1: milligram gallic acid equivalent per gram of the 
dry sample; mg QE g−1: milligram quercetin equivalent  per gram dry sample; ND: not determined 
 
 
Table 6. Cytotoxicity of E. camaledulensis aqueous acetone extract on MCF-7, Hep-2, HepG-2, HeLa, 
HCT-116 and Caco-2 cell lines. 
 
 
 
 
 
 
The cell viability of different cell lines was determined with respect to the control by SRB assay, after 48 h 
treatment with E. camaledulensis aqueous acetone extract and doxorubicin. The concentration range was 0 to 
200 µg/mL for the aqueous acetone extract and 0-50 µg/mL for doxorubicin. Values represent the mean of six 
measurements ± SE.  
 
 
 
% 
Area 
Tentative structural 
assignment 
Fragments  (M-2H)
2-  (M-H)
-  DAD  tR  N 
0.47  sanguiin H10-like ellagitannin 
dimer 
935.06, 633.07,  301.00, 169.02  783.08  1567.17  216.6, 268.8  12.2  1 
15.22 
 
ellagitannin dimer   935.09, 785.09, 633.07,  301.00, 
169.02 
784.08  1569.17  218.6, 266.6  14.9  2 
18.22    ellagitannin dimer   935.08, 785.08, 765.05, 633.08,  
301.00, 169.02 
784.08  1569.17  218.6, 264.5  16.6  3 
17.63  sanguiin H10-like ellagitannin 
dimer 
935.08, 633.07,  301.00, 169.02  783.07  1567.17  214.8, 262.5  17.3  4 
39.80  ellagitannin dimer   935.09, 765.05, 633.07,  301.00, 
169.02 
784.10  1569.18  218.8, 266.6  18.5  5 
1.35  ellagitannin dimer   935.08, 785.08, 765.05, 633.07,  
301.00, 169.02 
784.10  1569.18  216.6, 268.8  19.5  6 
2.69  trigalloyl-HHDP-
glucopyranose 
785.09, 301.00, 169.01  468.05  937.10  218.6, 271.0  20.6  7 
4.50  ellagitannin dimer   935.06, 633.07,  301.00, 169.02  860.08  1721.18  218.6, 271.0  21.9  8 
  DPPH
.  Deoxyribose  Super oxide 
anion 
Phenol content 
(mg GAE g−1) 
Flavonoid content 
(mg QE g−1) 
Total extract
  
14.0 ± 0.2  ND  106.6 ± 0.8  364.1 ± 8.2  80.5 ± 0.9 
Column fractions:           
Water Fr I  47.8 ± 0.7  97.0 ± 1.3  491.2 ± 11.4  110.1 ± 18.1  53.0 ± 0.6 
30% MeOH Fr II  14.0 ± 0.6  22.0 ± 1.1  43.9 ± 0.9  653.5 ± 21.5  129.5 ± 1.1 
60% MeOH Fr III  13.4 ± 0.3  37.4 ± 1.1  50.9 ± 4.2  729.1 ± 8.9  91.9 ± 0.8 
MeOH Fr IV  13.4 ± 0.1  19.2 ± 1.1  58.5 ± 1.9  701.1± 16.7  64.8 ± 0.3 
Quercetin  19.7 ± 1.0  3.9 ± 1.2       
Gallic acid  17.9 ± 0.9         
L-Ascorbic acid      56.7 ± 3.9     
  IC 50 (µg/mL)     
Caco-2  HCT-116  HeLa  HepG-2  Hep-2  MCF-7   
38.3  33.3  49.0  38.7  57.7  36.5  Total extract 
             
3.4  4.5  4.8  4.2  3.6  4.8  Doxorubicin 279                                Phenolic from Eucalyptus camaldulensis 
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